Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

Abstract

ADVANCES in neurotransmitter receptor identification and quantification by biochemical techniques involving radiolabelled analogues of putative neurotransmitters have led to the characterisation of a number of receptor systems in mammalian brain tissue1; these include the catecholamines2,3, 5-HT4, glycine5 and GABA6 receptors. The development of these techniques has provided a means of screening chemical compounds for their effects on different receptor systems7. The central nervous system effects of (±)-propranolol (Inderal, ICI) in animals are well documented8,9. This drug has therapeutic benefit in man in anxiety10, and is also reported to have similar benefit in schizophrenia11,12, essential tremor13 and drug dependence14. The origin of these effects is not understood but theories about its mode of action include β-adrenergic blockade15, membrane stabilisation8 and a 5-HT receptor blocking action16,17. We report here that propranolol a stereospecific affinity for the 5-HT receptor from rat brain which is similar in magnitude to the putative 5-HT receptor blocking drug methylsergide.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Snyder, S. H. & Bennett, J. P. A. Rev. Physiol. 38, 153–175 (1976).

    Article  CAS  Google Scholar 

  2. Burt, D. R., Creese, I. & Snyder, S. H. Molec. Pharmac. 12, 800–812 (1976).

    CAS  Google Scholar 

  3. Alexander, R. W., Davis, J. N. & Lefkowitz, R. J. Nature 258, 437–440 (1975).

    Article  CAS  PubMed  Google Scholar 

  4. Bennett, J. P. & Snyder, S. H. Molec. Pharmac. 12, 373–389 (1976).

    CAS  Google Scholar 

  5. Young, A. B. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 70, 2832–2836 (1973).

    Article  CAS  Google Scholar 

  6. Enna, S. J. & Snyder, S. H. Brain Res. 100, 81–97 (1975).

    Article  CAS  PubMed  Google Scholar 

  7. Enna, S. J., Bennett, J. P., Burt, D. R., Creese, I. & Snyder, S. H. Nature 263, 338–341 (1976).

    Article  CAS  PubMed  Google Scholar 

  8. Bainbridge, J. G. & Greenwood, D. T. Neuropharmacology 10, 453–458 (1971).

    Article  CAS  PubMed  Google Scholar 

  9. Jefferson, J. W. Archs gen. Psychiat. 31, 681–691 (1974).

    Article  CAS  Google Scholar 

  10. Granville-Grossman, K. L. & Turner, P. Lancet i, 788–790 (1966).

    Article  Google Scholar 

  11. Atsmon, A. et al. Folia psychiat. neurol, neurochir. neerl. 74, 251–258 (1971).

    Google Scholar 

  12. Yorkston, N. J., Zaki, S. A., Malik, M. K. U., Morrison, R. C. & Harvard, C. W. H. Br. Med. J. 4, 633–635 (1974).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Sevitt, I. Practitioner 207, 677–678 (1971).

    CAS  PubMed  Google Scholar 

  14. Grosz, H. J. Lancet ii, 564–566 (1972).

    Article  Google Scholar 

  15. Bonn, J. A. & Turner, P. Lancet i, 1355–1356 (1971).

    Article  Google Scholar 

  16. Weinstock, M. & Schechter, Y. Eur. J. Pharmac. 32, 293–301 (1975).

    Article  CAS  Google Scholar 

  17. Green, A. R. & Grahame-Smith, D. G. Nature 262, 594–596 (1976).

    Article  CAS  PubMed  Google Scholar 

  18. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265–275 (1951).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MIDDLEMISS, D., BLAKEBOROUGH, L. & LEATHER, S. Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor. Nature 267, 289–290 (1977). https://doi.org/10.1038/267289a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/267289a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing